<Study> HSBC Research Evaluates Ratings and Target Prices for Chinese Insurers (Table)
H Shares Performance: China Life and Ping An saw increases in share prices, while CPIC and NCI experienced slight declines; short selling ratios indicate varying investor sentiment across these companies.
A Shares Performance: China Life and Ping An of China had mixed results, with Ping An's rating upgraded from Hold to Buy, while NCI maintained a Hold rating despite a price increase.
Investment Ratings: Analysts have assigned ratings of Hold, Buy, and Underweight to various insurance companies, reflecting differing outlooks on their future performance.
Market Insights: CICC anticipates a new era in China's commercial health insurance sector, emphasizing four key areas for development.
Get Free Real-Time Notifications for Any Stock
Analyst Views on 01336
About the author
<Study> HSBC Research Evaluates Ratings and Target Prices for Chinese Insurers (Table)
H Shares Performance: China Life and Ping An saw increases in share prices, while CPIC and NCI experienced slight declines; short selling ratios indicate varying investor sentiment across these companies.
A Shares Performance: China Life and Ping An of China had mixed results, with Ping An's rating upgraded from Hold to Buy, while NCI maintained a Hold rating despite a price increase.
Investment Ratings: Analysts have assigned ratings of Hold, Buy, and Underweight to various insurance companies, reflecting differing outlooks on their future performance.
Market Insights: CICC anticipates a new era in China's commercial health insurance sector, emphasizing four key areas for development.
HSBC Research: Continued Optimism for Chinese Life Insurers; PING AN Named Top Choice in the Sector
Strong 2025 Results: Chinese insurers reported robust results for 2025, driven by higher investment returns from a stock market rebound, according to HSBC Global Research.
Shift in Investment Strategy: Insurers are changing their product mix towards participating products with lower guaranteed returns, focusing on creating new business value.
PING AN Upgrade: HSBC upgraded PING AN OF CHINA's A-shares from Hold to Buy, favoring it over CHINA LIFE, and identified it as a top pick due to its strong agency team and enhanced bargaining power with banks.
Cautious Outlook on NCI and CHINA LIFE: HSBC expressed caution regarding NCI and CHINA LIFE, highlighting their higher sensitivity to capital market fluctuations compared to PING AN.
